+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Virus like Particle Vaccines Market - Global Forecast 2025-2030- Product Image
Virus like Particle Vaccines Market - Global Forecast 2025-2030- Product Image
Sale

Virus like Particle Vaccines Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 197 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6131590
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Virus-like particle (VLP) vaccines are redefining immunization strategies, offering a modular and innovative approach that enables strong, targeted immunity while reducing safety concerns. As industry focus shifts to scalable, next-generation vaccine platforms, senior decision-makers must understand the forces shaping this dynamic market.

Market Snapshot: Virus-like Particle Vaccine Market Trends

Driven by advances in structural biology and recombinant technology, the virus-like particle vaccine market is poised for growth, with expanded investment in research, manufacturing, and translational partnerships. Market participants, from global biopharmaceutical firms to regional developers, are accelerating efforts to address diverse indications, leveraging computational modeling, advanced expression systems, and modular assembly to capture opportunities in both preventive and therapeutic vaccines. This momentum is fostered by strategic alliances, streamlined regulatory pathways, and growing demand for flexible, targeted immunization solutions.

Scope & Segmentation Analysis

This report delivers a granular breakdown of the virus-like particle vaccine market across key segments, geographies, and platform types:

  • Indication: Hepatitis B, HPV (bivalent, nonavalent, quadrivalent), Influenza (quadrivalent, trivalent), Norovirus
  • Vaccine Type: Prophylactic, Therapeutic
  • Platform Type: Chimeric, Recombinant, Synthetic
  • Route of Administration: Intramuscular, Intranasal, Oral, Subcutaneous
  • End User: Academic and research institutes, Clinics, Hospitals, Pharma and biotech companies
  • Regional Coverage: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, Russia, United Arab Emirates, South Africa, and other major markets), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, and more)
  • Company Landscape: GlaxoSmithKline plc, Merck & Co., Inc., Novavax, Inc., Dynavax Technologies Corporation, VBI Vaccines, Inc., Emergent BioSolutions Inc., Valneva SE, Bavarian Nordic A/S, SK bioscience Co., Ltd., Medicago Inc.

Key Takeaways for Senior Decision-Makers

  • Virus-like particle vaccines provide customizable, self-assembling structures, allowing precise epitope display for robust immune activation across a wide range of disease targets.
  • Technological advances such as AI-driven antigen selection and high-throughput expression platforms have accelerated development timelines and improved batch consistency.
  • Collaborative ecosystems are enabling joint innovation between biotechs, academic consortia, and established pharmaceutical players, replacing earlier siloed approaches.
  • Emerging interest in combination and multivalent VLP vaccines is addressing the growing need for broad-spectrum, outbreak-responsive immunizations in both established and novel indications.
  • Regional variations in regulatory frameworks and manufacturing capacity are prompting investments in localized production, adaptive regulatory strategies, and technology transfer initiatives.
  • Industry leaders are differentiating portfolios through targeted acquisitions, integration of synthetic scaffold technologies, and adoption of flexible, single-use bioreactor systems.

Tariff Impact: Strategic Shifts in Supply Chains and Investments

The introduction of revised United States tariff policies in 2025 has compelled the industry to rethink sourcing and manufacturing strategies. Increased duties on key biological reagents have led to higher production costs, prompting companies to explore localized hubs and alternative suppliers. Research groups are increasingly forming in-kind partnerships and sharing resources to offset budget pressures. Regulatory support for allowable cost pass-throughs has ensured clinical trial continuity, while investors are targeting organizations with resilient supply chain architectures.

Methodology & Data Sources

This report is underpinned by a comprehensive research framework that integrates peer-reviewed publications, regulatory filings, and patent literature with proprietary databases and qualitative interviews. Leading opinion leaders from academia, clinical research, and regulatory agencies provided validation and expert insight throughout the analysis. Supply chain trends, tariff schedules, and development pipelines were systematically triangulated to ensure a balanced, reliable perspective.

Why This Report Matters

  • Enables strategic planning by offering an actionable, segmented view of emerging opportunities and technology trajectories in virus-like particle vaccines.
  • Guides procurement, regulatory, and R&D decisions in a rapidly evolving market environment shaped by partnerships, tariff policies, and regional capabilities.
  • Equips executives to drive sustainable portfolio growth by illuminating leading competitors, evolving supply chain strategies, and regional investment priorities.

Conclusion

Virus-like particle vaccines are reshaping global immunization with precision-engineered, modular solutions. By leveraging the strategic insights in this report, stakeholders can optimize portfolios, enhance resilience, and position for leadership in the next generation of vaccine development.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Advancements in modular VLP platforms enabling rapid response to emerging viral threats
5.2. Integration of nanoparticle engineering technologies to enhance VLP stability and immunogenicity
5.3. Expansion of VLP vaccine pipelines targeting non-viral diseases such as cancer and autoimmune disorders
5.4. Adoption of cell-free protein synthesis for scalable and cost-effective VLP production
5.5. Collaboration between biotech startups and big pharma to accelerate VLP clinical trials and regulatory approval
5.6. Utilization of mRNA-encoded VLP constructs to combine benefits of mRNA and particulate delivery
5.7. Emergence of adjuvant optimization strategies to improve VLP-induced cellular and humoral immune responses
5.8. Development of thermostable VLP formulations for distribution in low-resource and remote settings
5.9. Application of advanced analytics and AI-driven design to predict epitope presentation on VLP surfaces
5.10. Strategic partnerships for VLP-based multivalent vaccines addressing multiple viral strains or pathogens
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Virus like Particle Vaccines Market, by Indication
8.1. Introduction
8.2. Hepatitis B
8.3. HPV
8.3.1. Bivalent
8.3.2. Nonavalent
8.3.3. Quadrivalent
8.4. Influenza
8.4.1. Quadrivalent
8.4.2. Trivalent
8.5. Norovirus
9. Virus like Particle Vaccines Market, by Vaccine Type
9.1. Introduction
9.2. Prophylactic
9.3. Therapeutic
10. Virus like Particle Vaccines Market, by Platform Type
10.1. Introduction
10.2. Chimeric
10.3. Recombinant
10.4. Synthetic
11. Virus like Particle Vaccines Market, by Route Of Administration
11.1. Introduction
11.2. Intramuscular
11.3. Intranasal
11.4. Oral
11.5. Subcutaneous
12. Virus like Particle Vaccines Market, by End User
12.1. Introduction
12.2. Academic And Research Institutes
12.3. Clinics
12.4. Hospitals
12.5. Pharma And Biotech Companies
13. Americas Virus like Particle Vaccines Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Virus like Particle Vaccines Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Virus like Particle Vaccines Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. GlaxoSmithKline plc
16.3.2. Merck & Co., Inc.
16.3.3. Novavax, Inc.
16.3.4. Dynavax Technologies Corporation
16.3.5. VBI Vaccines, Inc.
16.3.6. Emergent BioSolutions Inc.
16.3.7. Valneva SE
16.3.8. Bavarian Nordic A/S
16.3.9. SK bioscience Co., Ltd.
16.3.10. Medicago Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. VIRUS LIKE PARTICLE VACCINES MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY VACCINE TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY VACCINE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY PLATFORM TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY PLATFORM TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. VIRUS LIKE PARTICLE VACCINES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. VIRUS LIKE PARTICLE VACCINES MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. VIRUS LIKE PARTICLE VACCINES MARKET: RESEARCHAI
FIGURE 26. VIRUS LIKE PARTICLE VACCINES MARKET: RESEARCHSTATISTICS
FIGURE 27. VIRUS LIKE PARTICLE VACCINES MARKET: RESEARCHCONTACTS
FIGURE 28. VIRUS LIKE PARTICLE VACCINES MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. VIRUS LIKE PARTICLE VACCINES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY HEPATITIS B, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY HEPATITIS B, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY HPV, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY HPV, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY BIVALENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY BIVALENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY NONAVALENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY NONAVALENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY QUADRIVALENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY QUADRIVALENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY HPV, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY HPV, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY INFLUENZA, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY INFLUENZA, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY QUADRIVALENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY QUADRIVALENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY TRIVALENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY TRIVALENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY INFLUENZA, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY INFLUENZA, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY NOROVIRUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY NOROVIRUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY PROPHYLACTIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY PROPHYLACTIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY THERAPEUTIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY PLATFORM TYPE, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY PLATFORM TYPE, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY CHIMERIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY CHIMERIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY RECOMBINANT, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY RECOMBINANT, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY SYNTHETIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY INTRANASAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY INTRANASAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY PHARMA AND BIOTECH COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY PHARMA AND BIOTECH COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY HPV, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY HPV, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY INFLUENZA, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY INFLUENZA, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY PLATFORM TYPE, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY PLATFORM TYPE, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY HPV, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY HPV, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY INFLUENZA, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY INFLUENZA, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY PLATFORM TYPE, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY PLATFORM TYPE, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 99. CANADA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 100. CANADA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 101. CANADA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY HPV, 2018-2024 (USD MILLION)
TABLE 102. CANADA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY HPV, 2025-2030 (USD MILLION)
TABLE 103. CANADA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY INFLUENZA, 2018-2024 (USD MILLION)
TABLE 104. CANADA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY INFLUENZA, 2025-2030 (USD MILLION)
TABLE 105. CANADA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 106. CANADA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 107. CANADA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY PLATFORM TYPE, 2018-2024 (USD MILLION)
TABLE 108. CANADA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY PLATFORM TYPE, 2025-2030 (USD MILLION)
TABLE 109. CANADA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 110. CANADA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 111. CANADA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 112. CANADA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 113. MEXICO VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 114. MEXICO VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 115. MEXICO VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY HPV, 2018-2024 (USD MILLION)
TABLE 116. MEXICO VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY HPV, 2025-2030 (USD MILLION)
TABLE 117. MEXICO VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY INFLUENZA, 2018-2024 (USD MILLION)
TABLE 118. MEXICO VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY INFLUENZA, 2025-2030 (USD MILLION)
TABLE 119. MEXICO VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 120. MEXICO VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 121. MEXICO VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY PLATFORM TYPE, 2018-2024 (USD MILLION)
TABLE 122. MEXICO VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY PLATFORM TYPE, 2025-2030 (USD MILLION)
TABLE 123. MEXICO VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 124. MEXICO VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 125. MEXICO VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 126. MEXICO VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 127. BRAZIL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 128. BRAZIL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 129. BRAZIL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY HPV, 2018-2024 (USD MILLION)
TABLE 130. BRAZIL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY HPV, 2025-2030 (USD MILLION)
TABLE 131. BRAZIL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY INFLUENZA, 2018-2024 (USD MILLION)
TABLE 132. BRAZIL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY INFLUENZA, 2025-2030 (USD MILLION)
TABLE 133. BRAZIL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 134. BRAZIL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 135. BRAZIL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY PLATFORM TYPE, 2018-2024 (USD MILLION)
TABLE 136. BRAZIL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY PLATFORM TYPE, 2025-2030 (USD MILLION)
TABLE 137. BRAZIL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 138. BRAZIL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 139. BRAZIL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 140. BRAZIL VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 141. ARGENTINA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 142. ARGENTINA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 143. ARGENTINA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY HPV, 2018-2024 (USD MILLION)
TABLE 144. ARGENTINA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY HPV, 2025-2030 (USD MILLION)
TABLE 145. ARGENTINA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY INFLUENZA, 2018-2024 (USD MILLION)
TABLE 146. ARGENTINA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY INFLUENZA, 2025-2030 (USD MILLION)
TABLE 147. ARGENTINA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 148. ARGENTINA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 149. ARGENTINA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY PLATFORM TYPE, 2018-2024 (USD MILLION)
TABLE 150. ARGENTINA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY PLATFORM TYPE, 2025-2030 (USD MILLION)
TABLE 151. ARGENTINA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 152. ARGENTINA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 153. ARGENTINA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 154. ARGENTINA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY HPV, 2018-2024 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY HPV, 2025-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY INFLUENZA, 2018-2024 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY INFLUENZA, 2025-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY PLATFORM TYPE, 2018-2024 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY PLATFORM TYPE, 2025-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 171. UNITED KINGDOM VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 172. UNITED KINGDOM VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 173. UNITED KINGDOM VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY HPV, 2018-2024 (USD MILLION)
TABLE 174. UNITED KINGDOM VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY HPV, 2025-2030 (USD MILLION)
TABLE 175. UNITED KINGDOM VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY INFLUENZA, 2018-2024 (USD MILLION)
TABLE 176. UNITED KINGDOM VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY INFLUENZA, 2025-2030 (USD MILLION)
TABLE 177. UNITED KINGDOM VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 178. UNITED KINGDOM VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 179. UNITED KINGDOM VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY PLATFORM TYPE, 2018-2024 (USD MILLION)
TABLE 180. UNITED KINGDOM VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY PLATFORM TYPE, 2025-2030 (USD MILLION)
TABLE 181. UNITED KINGDOM VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 182. UNITED KINGDOM VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 184. UNITED KINGDOM VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 185. GERMANY VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 186. GERMANY VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 187. GERMANY VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY HPV, 2018-2024 (USD MILLION)
TABLE 188. GERMANY VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY HPV, 2025-2030 (USD MILLION)
TABLE 189. GERMANY VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY INFLUENZA, 2018-2024 (USD MILLION)
TABLE 190. GERMANY VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY INFLUENZA, 2025-2030 (USD MILLION)
TABLE 191. GERMANY VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 192. GERMANY VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 193. GERMANY VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY PLATFORM TYPE, 2018-2024 (USD MILLION)
TABLE 194. GERMANY VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY PLATFORM TYPE, 2025-2030 (USD MILLION)
TABLE 195. GERMANY VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 196. GERMANY VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 197. GERMANY VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 198. GERMANY VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 199. FRANCE VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 200. FRANCE VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 201. FRANCE VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY HPV, 2018-2024 (USD MILLION)
TABLE 202. FRANCE VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY HPV, 2025-2030 (USD MILLION)
TABLE 203. FRANCE VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY INFLUENZA, 2018-2024 (USD MILLION)
TABLE 204. FRANCE VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY INFLUENZA, 2025-2030 (USD MILLION)
TABLE 205. FRANCE VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 206. FRANCE VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 207. FRANCE VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY PLATFORM TYPE, 2018-2024 (USD MILLION)
TABLE 208. FRANCE VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY PLATFORM TYPE, 2025-2030 (USD MILLION)
TABLE 209. FRANCE VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 210. FRANCE VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 211. FRANCE VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 212. FRANCE VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 213. RUSSIA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 214. RUSSIA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 215. RUSSIA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY HPV, 2018-2024 (USD MILLION)
TABLE 216. RUSSIA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY HPV, 2025-2030 (USD MILLION)
TABLE 217. RUSSIA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY INFLUENZA, 2018-2024 (USD MILLION)
TABLE 218. RUSSIA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY INFLUENZA, 2025-2030 (USD MILLION)
TABLE 219. RUSSIA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 220. RUSSIA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 221. RUSSIA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY PLATFORM TYPE, 2018-2024 (USD MILLION)
TABLE 222. RUSSIA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY PLATFORM TYPE, 2025-2030 (USD MILLION)
TABLE 223. RUSSIA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 224. RUSSIA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 225. RUSSIA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 226. RUSSIA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 227. ITALY VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 228. ITALY VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 229. ITALY VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY HPV, 2018-2024 (USD MILLION)
TABLE 230. ITALY VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY HPV, 2025-2030 (USD MILLION)
TABLE 231. ITALY VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY INFLUENZA, 2018-2024 (USD MILLION)
TABLE 232. ITALY VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY INFLUENZA, 2025-2030 (USD MILLION)
TABLE 233. ITALY VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 234. ITALY VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 235. ITALY VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY PLATFORM TYPE, 2018-2024 (USD MILLION)
TABLE 236. ITALY VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY PLATFORM TYPE, 2025-2030 (USD MILLION)
TABLE 237. ITALY VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 238. ITALY VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 239. ITALY VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 240. ITALY VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 241. SPAIN VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 242. SPAIN VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 243. SPAIN VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY HPV, 2018-2024 (USD MILLION)
TABLE 244. SPAIN VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY HPV, 2025-2030 (USD MILLION)
TABLE 245. SPAIN VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY INFLUENZA, 2018-2024 (USD MILLION)
TABLE 246. SPAIN VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY INFLUENZA, 2025-2030 (USD MILLION)
TABLE 247. SPAIN VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 248. SPAIN VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 249. SPAIN VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY PLATFORM TYPE, 2018-2024 (USD MILLION)
TABLE 250. SPAIN VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY PLATFORM TYPE, 2025-2030 (USD MILLION)
TABLE 251. SPAIN VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 252. SPAIN VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 253. SPAIN VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 254. SPAIN VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 255. UNITED ARAB EMIRATES VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 256. UNITED ARAB EMIRATES VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 257. UNITED ARAB EMIRATES VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY HPV, 2018-2024 (USD MILLION)
TABLE 258. UNITED ARAB EMIRATES VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY HPV, 2025-2030 (USD MILLION)
TABLE 259. UNITED ARAB EMIRATES VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY INFLUENZA, 2018-2024 (USD MILLION)
TABLE 260. UNITED ARAB EMIRATES VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY INFLUENZA, 2025-2030 (USD MILLION)
TABLE 261. UNITED ARAB EMIRATES VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 262. UNITED ARAB EMIRATES VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 263. UNITED ARAB EMIRATES VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY PLATFORM TYPE, 2018-2024 (USD MILLION)
TABLE 264. UNITED ARAB EMIRATES VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY PLATFORM TYPE, 2025-2030 (USD MILLION)
TABLE 265. UNITED ARAB EMIRATES VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 266. UNITED ARAB EMIRATES VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 267. UNITED ARAB EMIRATES VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 268. UNITED ARAB EMIRATES VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 269. SAUDI ARABIA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 270. SAUDI ARABIA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 271. SAUDI ARABIA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY HPV, 2018-2024 (USD MILLION)
TABLE 272. SAUDI ARABIA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY HPV, 2025-2030 (USD MILLION)
TABLE 273. SAUDI ARABIA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY INFLUENZA, 2018-2024 (USD MILLION)
TABLE 274. SAUDI ARABIA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY INFLUENZA, 2025-2030 (USD MILLION)
TABLE 275. SAUDI ARABIA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 276. SAUDI ARABIA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 277. SAUDI ARABIA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY PLATFORM TYPE, 2018-2024 (USD MILLION)
TABLE 278. SAUDI ARABIA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY PLATFORM TYPE, 2025-2030 (USD MILLION)
TABLE 279. SAUDI ARABIA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 280. SAUDI ARABIA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 281. SAUDI ARABIA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 282. SAUDI ARABIA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 283. SOUTH AFRICA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 284. SOUTH AFRICA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 285. SOUTH AFRICA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY HPV, 2018-2024 (USD MILLION)
TABLE 286. SOUTH AFRICA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY HPV, 2025-2030 (USD MILLION)
TABLE 287. SOUTH AFRICA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY INFLUENZA, 2018-2024 (USD MILLION)
TABLE 288. SOUTH AFRICA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY INFLUENZA, 2025-2030 (USD MILLION)
TABLE 289. SOUTH AFRICA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 290. SOUTH AFRICA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 291. SOUTH AFRICA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY PLATFORM TYPE, 2018-2024 (USD MILLION)
TABLE 292. SOUTH AFRICA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY PLATFORM TYPE, 2025-2030 (USD MILLION)
TABLE 293. SOUTH AFRICA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 294. SOUTH AFRICA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 295. SOUTH AFRICA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 296. SOUTH AFRICA VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 297. DENMARK VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 298. DENMARK VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 299. DENMARK VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY HPV, 2018-2024 (USD MILLION)
TABLE 300. DENMARK VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY HPV, 2025-2030 (USD MILLION)
TABLE 301. DENMARK VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY INFLUENZA, 2018-2024 (USD MILLION)
TABLE 302. DENMARK VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY INFLUENZA, 2025-2030 (USD MILLION)
TABLE 303. DENMARK VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 304. DENMARK VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 305. DENMARK VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY PLATFORM TYPE, 2018-2024 (USD MILLION)
TABLE 306. DENMARK VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY PLATFORM TYPE, 2025-2030 (USD MILLION)
TABLE 307. DENMARK VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 308. DENMARK VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 309. DENMARK VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 310. DENMARK VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 311. NETHERLANDS VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 312. NETHERLANDS VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 313. NETHERLANDS VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY HPV, 2018-2024 (USD MILLION)
TABLE 314. NETHERLANDS VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY HPV, 2025-2030 (USD MILLION)
TABLE 315. NETHERLANDS VIRUS LIKE PARTICLE VACCINES MARKET SIZE, BY INFLU

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Virus like Particle Vaccines market report include:
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Novavax, Inc.
  • Dynavax Technologies Corporation
  • VBI Vaccines, Inc.
  • Emergent BioSolutions Inc.
  • Valneva SE
  • Bavarian Nordic A/S
  • SK bioscience Co., Ltd.
  • Medicago Inc.

Related Topics

Related Reports

Multivalent Influenza Vaccines Market - Global Forecast to 2030 - Product Image

Multivalent Influenza Vaccines Market - Global Forecast to 2030

  • Report
  • 194 Pages
  • Global
From
Avian Influenza Vaccines Market - Global Forecast 2025-2030 - Product Image

Avian Influenza Vaccines Market - Global Forecast 2025-2030

  • Report
  • 189 Pages
  • Global
From
Influenza Vaccine Market: Analysis by Valency, Vaccine Type, Technology, Age Group, Route of Administration, Distribution Channel, and Region - Size, Trends and Forecasts to 2030 - Product Image

Influenza Vaccine Market: Analysis by Valency, Vaccine Type, Technology, Age Group, Route of Administration, Distribution Channel, and Region - Size, Trends and Forecasts to 2030

  • Report
  • 165 Pages
  • Global
From
Nasal Spray Influenza Vaccine Global Market Report 2025 - Product Image

Nasal Spray Influenza Vaccine Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Influenza Vaccines - Global Strategic Business Report - Product Image

Influenza Vaccines - Global Strategic Business Report

  • Report
  • 554 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.